TY - JOUR
T1 - Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions
T2 - the PROGRESS-CTO perforation score
AU - Kostantinis, Spyridon
AU - Simsek, Bahadir
AU - Karacsonyi, Judit
AU - Alaswad, Khaldoon
AU - Jaffer, Farouc A.
AU - Khatri, Jaikirshan J.
AU - Choi, James W.
AU - Jaber, Wissam A.
AU - Rinfret, Stéphane
AU - Nicholson, William
AU - Patel, Mitul P.
AU - Mahmud, Ehtisham
AU - Toma, Catalin
AU - Davies, Rhian E.
AU - Kerrigan, Jimmy L.
AU - Haddad, Elias V.
AU - Gorgulu, Sevket
AU - Abi-Rafeh, Nidal
AU - ElGuindy, Ahmed M.
AU - Goktekin, Omer
AU - Allana, Salman
AU - Nicholas Burke, M.
AU - Mastrodemos, Olga C.
AU - Rangan, Bavana Venkata
AU - Brilakis, Emmanouil S.
N1 - Publisher Copyright:
© Europa Digital & Publishing 2023. All rights reserved.
PY - 2023/1
Y1 - 2023/1
N2 - Background: Coronary artery perforation is a feared complication of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) and often leads to serious adverse clinical events. Aims: We sought to develop a risk score to predict clinical coronary artery perforation in patients undergoing CTO PCI. Methods: We analysed clinical and angiographic parameters from 9,618 CTO PCIs in the Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (PROGRESS-CTO). Logistic regression prediction modelling was used to identify variables independently associated with clinical perforation, and the model was internally validated with bootstrapping. Clinical coronary artery perforation was defined as any perforation requiring treatment. Results: The incidence of clinical coronary perforation was 3.8% (n=367). Five factors were independently associated with perforation and were included in the score: patient age ≥65 years +1 point (odds ratio [OR] 1.79, 95% confidence interval [CI]: 1.37-2.33), moderate/severe calcification +1 point (OR 1.85, 95% CI: 1.41-2.42), blunt/no stump +1 point (OR 1.45, 95% CI: 1.10-1.92), use of antegrade dissection and reentry +1 point (OR 2.43, 95% CI: 1.61-3.69), and use of the retrograde approach +2 points (OR 4.02, 95% CI: 2.95-5.46). The resulting score showed acceptable performance on receiver operating characteristic (ROC) curve (area under the curve [AUC]: 0.741, 95% CI: 0.712-0.773). The Hosmer-Lemeshow test indicated a good fit (p=0.991), and internal validation with bootstrapping demonstrated good agreement with the model with observed AUC: 0.736 (95% bias-corrected CI: 0.706-0.767). Conclusions: The PROGRESS-CTO perforation score may be a useful tool for predicting clinical coronary perforation during CTO PCI.
AB - Background: Coronary artery perforation is a feared complication of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) and often leads to serious adverse clinical events. Aims: We sought to develop a risk score to predict clinical coronary artery perforation in patients undergoing CTO PCI. Methods: We analysed clinical and angiographic parameters from 9,618 CTO PCIs in the Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (PROGRESS-CTO). Logistic regression prediction modelling was used to identify variables independently associated with clinical perforation, and the model was internally validated with bootstrapping. Clinical coronary artery perforation was defined as any perforation requiring treatment. Results: The incidence of clinical coronary perforation was 3.8% (n=367). Five factors were independently associated with perforation and were included in the score: patient age ≥65 years +1 point (odds ratio [OR] 1.79, 95% confidence interval [CI]: 1.37-2.33), moderate/severe calcification +1 point (OR 1.85, 95% CI: 1.41-2.42), blunt/no stump +1 point (OR 1.45, 95% CI: 1.10-1.92), use of antegrade dissection and reentry +1 point (OR 2.43, 95% CI: 1.61-3.69), and use of the retrograde approach +2 points (OR 4.02, 95% CI: 2.95-5.46). The resulting score showed acceptable performance on receiver operating characteristic (ROC) curve (area under the curve [AUC]: 0.741, 95% CI: 0.712-0.773). The Hosmer-Lemeshow test indicated a good fit (p=0.991), and internal validation with bootstrapping demonstrated good agreement with the model with observed AUC: 0.736 (95% bias-corrected CI: 0.706-0.767). Conclusions: The PROGRESS-CTO perforation score may be a useful tool for predicting clinical coronary perforation during CTO PCI.
KW - chronic coronary total occlusion
KW - coronary rupture
KW - pericardial effusion
UR - http://www.scopus.com/inward/record.url?scp=85147045621&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85147045621&partnerID=8YFLogxK
U2 - 10.4244/EIJ-D-22-00593
DO - 10.4244/EIJ-D-22-00593
M3 - Article
C2 - 36281650
AN - SCOPUS:85147045621
SN - 1774-024X
VL - 18
SP - 1022
EP - 1030
JO - EuroIntervention
JF - EuroIntervention
IS - 12
ER -